EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

Propranolol and Oxytocin‐Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study

Mrinalini Balki iD, Lauren M Miller, Jayalakshmi Caliaperumal, Stella Wang, Ella Huszti, John C Kingdom

BJOG: An International Journal of Obstetrics & Gynaecology · 2025

DOI: 10.1111/1471-0528.18146 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025. Verfasst von Mrinalini Balki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Myometrium, Oxytocics, Oxytocin, Propranolol. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the effect of propranolol on myometrial contractions induced by low dose and high dose oxytocin.

Design

Prospective ex vivo laboratory study.

Setting

Mount Sinai Hospital, Toronto. Population Full‐term parturients who underwent elective caesarean deliveries (CD).

Methods

Two models were developed in the organ bath chamber using myometrial samples obtained during CDs: (i) Labor induction‐augmentation model with low‐dose oxytocin consisting of 3 groups with the administration of propranolol before and during simulated labor, and a control group. (ii) Postpartum haemorrhage (PPH) model with high‐dose oxytocin consisting of 4 groups with the administration of propranolol during and/or after augmented labor (desensitised with oxytocin), and a control group. Main Outcome Measures Myometrial contractility was recorded using force transducers.

Results

In the labor induction‐augmentation model, propranolol pre‐treatment produced a higher area under the curve (AUC) of myometrial contractility induced by low‐dose oxytocin (relative percentage difference [diff]: 20.4%; 95% CI [1.4%, 43.2%], p = 0.035) compared to control; however, no difference was observed when propranolol was given after the initiation of labor. In the oxytocin‐desensitised PPH model, the AUC of myometrial contractility induced by high‐dose oxytocin was improved with propranolol pre‐treatment (diff 25.4% [0.2%, 56.8%], p = 0.048), co‐treatment (diff 26.7% [3.7%, 54.7%], p = 0.02), and both pre‐ and co‐treatment (diff 28.4% [7.0%, 54.1%], p = 0.007) when compared to the control group.

Conclusions

Our ex vivo study suggests that propranolol can augment uterine activity by approximately 20%–25% when administered early during labor induction and augmentation. Clinical studies are warranted to determine the relevance of these findings in vivo. Trial Registration ClinicalTrials.gov Identifier: NCT03434444; https://clinicaltrials.gov/

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyometriumOxytocicsOxytocinPropranololUterine ContractionAdultFemaleHumansPregnancyCesarean SectionLabor, InducedPostpartum HemorrhageProspective Studies

Stichwörter der Autor:innen

caesarean deliverylabor augmentationlabor inductionmyometrial contractilityoxytocinprimary postpartum haemorrhagepropranolol

Substanzen

OxytocicsOxytocinPropranolol

Autor:innen und Institutionen

  • Department of Anesthesia and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Biostatistics Department, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Mrinalini Balki

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Balki, M., Miller, L. M., Caliaperumal, J., Wang, S., Huszti, E., & Kingdom, J. C. (2025). Propranolol and Oxytocin‐Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18146

Vancouver

Balki M, Miller LM, Caliaperumal J, Wang S, Huszti E, Kingdom JC. Propranolol and Oxytocin‐Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.18146

BibTeX
@article{Balki2025,
  author = {Balki, Mrinalini and Miller, Lauren M and Caliaperumal, Jayalakshmi and Wang, Stella and Huszti, Ella and Kingdom, John C},
  title = {Propranolol and Oxytocin‐Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2025},
  doi = {10.1111/1471-0528.18146}
}
Kostenlos starten →